ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.800
+0.230 (6.44%)
Jan 22, 2026, 4:00 PM EST - Market closed
ADC Therapeutics Employees
As of December 31, 2024, ADC Therapeutics had 265 total employees, including 263 full-time and 2 part-time employees. The number of employees decreased by 9 or -3.28% compared to the previous year.
Employees
265
Change (1Y)
-9
Growth (1Y)
-3.28%
Revenue / Employee
$283,808
Profits / Employee
-$629,966
Market Cap
470.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 265 | -9 | -3.28% | 263 | 2 |
| Dec 31, 2023 | 274 | -43 | -13.56% | 273 | 1 |
| Dec 31, 2022 | 317 | 5 | 1.60% | 317 | 0 |
| Dec 31, 2021 | 312 | 104 | 50.00% | 312 | 0 |
| Dec 31, 2020 | 208 | - | - | 208 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 368 |
| Bicycle Therapeutics | 305 |
| 4D Molecular Therapeutics | 227 |
| Absci | 157 |
| Aclaris Therapeutics | 64 |
| Contineum Therapeutics | 41 |
| Anavex Life Sciences | 34 |
| Eupraxia Pharmaceuticals | 33 |
ADCT News
- 7 days ago - ADC Therapeutics SA (ADCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 14 days ago - ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - PRNewsWire
- 15 days ago - ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 20 days ago - ADC Therapeutics Announces New Employee Inducement Grant - PRNewsWire
- 7 weeks ago - ADC Therapeutics SA (ADCT) Discusses Updated Results From LOTIS-7 Trial Evaluating ZYNLONTA Plus Glofitamab in Relapsed or Refractory DLBCL Transcript - Seeking Alpha
- 7 weeks ago - ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma - PRNewsWire
- 7 weeks ago - ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial - PRNewsWire
- 7 weeks ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire